New York, 27 January 2026 — United Nations Secretary-General António Guterres has appointed 15 leading experts to the Independent Expert Advisory Panel for the Multidimensional Vulnerability Index ...

For decades, design followed a singular truth. Whether it was the insistence that “form follows function” or the later pivot toward “form follows emotion,” the industry tended to adhere to a simple ...

This 2025 Global Multidimensional Poverty Index (MPI) report, for the first time, overlays data on climate hazards and multidimensional poverty to assess how exposed poor people are to environmental ...

Community driven content discussing all aspects of software development from DevOps to design patterns. Here are the most important concepts developers must know when they size Java arrays and deal ...

Community driven content discussing all aspects of software development from DevOps to design patterns. To find the size or length of a Java array, follow these four steps Declare a variable of type ...

Plants synthesize an extensive array of secondary metabolites in response to diverse biotic and abiotic stresses. These metabolites function not only as defensive compounds but also constitute ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Traditionally, discussions on poverty have centred on income poverty, both in analytical debates and measurements. Income-based metrics have long been used to gauge deprivation, shaping the dominant ...

The Java landscape—including key players and users—is experiencing a significant shift. Oracle Java has been the most popular way to run enterprise Java applications and workloads for years. However, ...

MSK-ACCESS powered with SOPHiA DDM: Performance analysis of a decentralized MSK-ACCESS solution. Molecular imaging research on 18F-FDG PET/CT and biomarker analysis to predict the efficacy of ...

Outcome of chemo-immunotherapy for extensive-stage small-cell lung cancer according to potential clinical trial eligibility: 3-year outcomes from prospective cohort study. Tifcemalimab combined with ...